Impact of Direct-Acting Antivirals on the Burden of HCV Infection Among Persons Who Inject Drugs and Men Who Have Sex With Men in the Swiss HIV Cohort Study

Publikation

Impact of Direct-Acting Antivirals on the Burden of HCV Infection Among Persons Who Inject Drugs and Men Who Have Sex With Men in the Swiss HIV Cohort Study

Wissenschaftlicher Artikel/Review - 26.06.2018

Salazar-Vizcaya Luisa, Rauch Andri, Béguelin Charles, Rougemont Mathieu, Hoffmann Matthias, Bernasconi Enos, Stoeckle Marcel, Cavassini Matthias, Braun Dominique, Fehr Jan, Wandeler Gilles, Swiss HIV Cohort Study

Zitation

Salazar-Vizcaya L, Rauch A, Béguelin C, Rougemont M, Hoffmann M, Bernasconi E, Stoeckle M, Cavassini M, Braun D, Fehr J, Wandeler G, Swiss HIV Cohort Study. Impact of Direct-Acting Antivirals on the Burden of HCV Infection Among Persons Who Inject Drugs and Men Who Have Sex With Men in the Swiss HIV Cohort Study. Open Forum Infect Dis 2018; 5:ofy154.

Art

Wissenschaftlicher Artikel/Review (Englisch)

Zeitschrift

Open Forum Infect Dis 2018; 5

Veröffentlichungsdatum

26.06.2018

ISSN (Druck)

2328-8957

Seiten

ofy154

Kurzbeschreibung/Zielsetzung

In the Swiss HIV Cohort Study, the number of people who inject drugs with replicating hepatitis C virus (HCV) infection decreased substantially after the introduction of direct-acting antivirals (DAAs). Among men who have sex with men, the increase in DAA uptake and efficacy was counterbalanced by frequent incident HCV infections.